These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7914668)

  • 1. Regional amino acid neurotransmitter changes in brains of spf/Y mice with congenital ornithine transcarbamylase deficiency.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Metab Brain Dis; 1994 Mar; 9(1):43-51. PubMed ID: 7914668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of congenital hyperammonemia on the cerebral and hepatic levels of the intermediates of energy metabolism in spf mice.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Biochem Biophys Res Commun; 1992 Apr; 184(2):746-51. PubMed ID: 1575747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Metabolism; 1993 Aug; 42(8):1039-46. PubMed ID: 8102193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for cholinergic neuronal loss in brain in congenital ornithine transcarbamylase deficiency.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Neurosci Lett; 1994 Aug; 178(1):63-5. PubMed ID: 7816342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sodium benzoate on cerebral and hepatic energy metabolites in spf mice with congenital hyperammonemia.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Biochem Pharmacol; 1993 Jan; 45(1):137-46. PubMed ID: 8424807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of hepatic cytochrome c oxidase activity and expression with acetyl-L-carnitine treatment in spf mice with an ornithine transcarbamylase deficiency.
    Mawal YR; Rama Rao KV; Qureshi IA
    Biochem Pharmacol; 1998 Jun; 55(11):1853-60. PubMed ID: 9714304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental study of hepatic glutamine synthetase in a mouse model of congenital hyperammonemia.
    Skarpetas A; Mawal Y; Qureshi IA
    Biochem Mol Biol Int; 1997 Sep; 43(1):133-9. PubMed ID: 9315291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in the MK-801 binding sites of the NMDA sub-type of glutamate receptor in a mouse model of congenital hyperammonemia: prevention by acetyl-L-carnitine.
    Rao KV; Qureshi IA
    Neuropharmacology; 1999 Mar; 38(3):383-94. PubMed ID: 10219976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrations of ammonia metabolism in ornithine carbamoyltransferase-deficient spf-ash mice and their prevention by treatment with urea cycle intermediate amino acids and an ornithine aminotransferase inactivator.
    Li MX; Nakajima T; Fukushige T; Kobayashi K; Seiler N; Saheki T
    Biochim Biophys Acta; 1999 Sep; 1455(1):1-11. PubMed ID: 10524224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient mitochondrial import of newly synthesized ornithine transcarbamylase (OTC) and correction of secondary metabolic alterations in spf(ash) mice following gene therapy of OTC deficiency.
    Zimmer KP; Bendiks M; Mori M; Kominami E; Robinson MB; Ye X; Wilson JM
    Mol Med; 1999 Apr; 5(4):244-53. PubMed ID: 10448647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased densities of binding sites for the peripheral-type benzodiazepine receptor ligand [3H]PK 11195 in congenital ornithine transcarbamylase-deficient sparse fur mouse.
    Rao VL; Qureshi IA; Butterworth RF
    Pediatr Res; 1993 Dec; 34(6):777-80. PubMed ID: 8108192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ornithine transcarbamylase deficiency: pathogenesis of the cerebral disorder and new prospects for therapy.
    Michalak A; Butterworth RF
    Metab Brain Dis; 1997 Sep; 12(3):171-82. PubMed ID: 9346466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Brain monoamines and behavior in hyperammonemic sparse-fur mice].
    Minakami K
    Nihon Yakurigaku Zasshi; 1994 May; 103(5):219-29. PubMed ID: 8188118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of [3H]MK801 binding sites in brain in congenital ornithine transcarbamylase deficiency.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Metab Brain Dis; 1995 Sep; 10(3):249-55. PubMed ID: 8830285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.
    Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y
    BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a central cholinergic deficit in congenital ornithine transcarbamylase deficiency.
    Butterworth RF
    Dev Neurosci; 1998; 20(4-5):478-84. PubMed ID: 9778587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ornithine restores ureagenesis capacity and mitigates hyperammonemia in Otc(spf-ash) mice.
    Marini JC; Lee B; Garlick PJ
    J Nutr; 2006 Jul; 136(7):1834-8. PubMed ID: 16772445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient hyperammonemia during aging in ornithine transcarbamylase-deficient, sparse-fur mice.
    Gushiken T; Yoshimura N; Saheki T
    Biochem Int; 1985 Nov; 11(5):637-43. PubMed ID: 4091843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sparse fur mouse as a model for gene therapy in ornithine carbamoyltransferase deficiency.
    Batshaw ML; Yudkoff M; McLaughlin BA; Gorry E; Anegawa NJ; Smith IA; Hyman SL; Robinson MB
    Gene Ther; 1995 Dec; 2(10):743-9. PubMed ID: 8750014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced ornithine transcarbamylase activity does not impair ureagenesis in Otc(spf-ash) mice.
    Marini JC; Lee B; Garlick PJ
    J Nutr; 2006 Apr; 136(4):1017-20. PubMed ID: 16549467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.